BIOMAR — BioMar A/S Income Statement
0.000.00%
- DKK12.85bn
- DKK16.02bn
- DKK16.53bn
Annual income statement for BioMar A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 17,878 | 16,616 | 16,534 |
| Cost of Revenue | |||
| Gross Profit | 3,105 | 3,398 | 3,613 |
| Selling / General / Administrative Expenses | |||
| Depreciation and Amortization | |||
| Unusual Expense / Income | |||
| Other Operating Expenses | |||
| Total Operating Expenses | 17,018 | 15,487 | 15,437 |
| Operating Profit | 860 | 1,129 | 1,097 |
| Total Net Non Operating Interest Income / Expense | |||
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | 654 | 945 | 1,021 |
| Provision for Income Taxes | |||
| Net Income After Taxes | 484 | 706 | 755 |
| Minority Interest | |||
| Net Income Before Extraordinary Items | |||
| Net Income | 461 | 675 | 714 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | 461 | 675 | 714 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | 4.86 | 6.72 | 7.53 |